rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Eli Lilly and Company

LLY · NYSE

Health CarePharmaceuticalsLeadingGLP-1

LLY stood above a rising 150-day average in 42 of the last 52 weekly readings, including each of the last 23 weeks. It is 13.2% above that average now. Pharmaceuticals: 32% of its 74 stocks in an uptrend (−7 points in four weeks); Health Care: 26% (−10 points in four weeks).

Statistics

Rotation
Leading
Weeks in an uptrend
23 in a row
Industry in uptrend
32% -7 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$3.0B
Officials’ trades on record
199

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 42 of 52 weeks.

20 Apr – 19 Oct
26%34%43%Apr 26Jun 26Jul 26Sep 26Oct 26

Pharmaceuticals: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$2.1B$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars. Not yet read: institutions.

Congress and officials

199 disclosed lines: House 166, Senate 26, executive 7; 55 people.

WhoDidAmountTraded
Dan Newhouse House: U.S. House ClerkWA04soldspouse$1k–$15k10 Jul 2026filed 17 Jul 2026
Michael A. Rulli House: U.S. House ClerkOH06sold$1k–$15k1 Jul 2026filed 7 Aug 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$50k–$100k10 Jun 2026filed 2 Jul 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$1k–$15k3 Jun 2026filed 22 Aug 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$50k–$100k18 May 2026filed 1 Jul 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$1k–$15k28 Apr 2026filed 1 Jul 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$1k–$15k14 Apr 2026filed 8 May 2026
Lizzie Fletcher House: U.S. House ClerkTX07sold$1k–$15k8 Apr 2026filed 1 May 2026
Byron Donalds House: U.S. House ClerkFL19boughtspouse$1k–$15k2 Apr 2026filed 13 May 2026
Byron Donalds House: U.S. House ClerkFL19bought$1k–$15k2 Apr 2026filed 13 May 2026
Alan Armstrong Senate: U.S. Senate eFDSenatorsold$1k–$15k27 Mar 2026filed 21 Jul 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$1k–$15k23 Mar 2026filed 14 May 2026

Insiders

Buy orders, 12 months0
Sale orders, 12 months29
Buyers · sellers0 · 5
WhoDidSharesTraded
Patrik JonssonEVP & President, LLY Int'lsold6,500at $1,175.1017 Aug 2026filed 18 Aug 2026
Donald A. ZakrowskiSVP, Finance, & CAOsold2,000at $1,185.0110 Aug 2026filed 11 Aug 2026
Anat HakimEVP, GC & Secretarysold5,000at $1,190.007 Aug 2026filed 10 Aug 2026
Ilya YuffaEVP&Pres, LLY USA&Global Capabsold2,500at $1,150.7710 Jun 2026filed 11 Jun 2026
Lilly Endowment IncOthersold13,620at $995.236 May 2026filed 7 May 2026
Lilly Endowment IncOthersold2,208at $996.186 May 2026filed 7 May 2026
Lilly Endowment Inc10% ownersold895at $1,085.117 Jan 2026filed 8 Jan 2026
Lilly Endowment Inc10% ownersold7,684at $1,086.757 Jan 2026filed 8 Jan 2026
Lilly Endowment Inc10% ownersold1,070at $1,087.807 Jan 2026filed 8 Jan 2026
Lilly Endowment Inc10% ownersold930at $1,088.977 Jan 2026filed 8 Jan 2026
Lilly Endowment Inc10% ownersold3,575at $1,090.187 Jan 2026filed 8 Jan 2026
Lilly Endowment Inc10% ownersold1,224at $1,091.057 Jan 2026filed 8 Jan 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Still reading this part; it fills in a moment.

Everyone who traded it

Gabrielle Sulzberger Company insiderDirector · last 21 Sep 20261 · 0
J. Erik Fyrwald Company insiderDirector · last 21 Sep 20261 · 0
Juan R. Luciano Company insiderDirector · last 21 Sep 20260 · 0
Ralph Alvarez Company insiderDirector · last 21 Sep 20261 · 0
Melissa Seymour Company insiderEVP, Global Quality · last 9 Sep 20260 · 0
Edgardo Hernandez Company insiderEVP & Pres., Mfg. Operations · last 2 Sep 20260 · 0
Eric Dozier Company insiderEVP, Chief People Officer · last 2 Sep 20260 · 0
Patrik Jonsson Company insiderEVP & President, LLY Int'l · last 17 Aug 20260 · 4
Donald A. Zakrowski Company insiderSVP, Finance, & CAO · last 10 Aug 20260 · 32
Anat Hakim Company insiderEVP, GC & Secretary · last 7 Aug 20260 · 1
Dan Newhouse HouseWA04 · last 10 Jul 20261 · 4
Michael A. Rulli HouseOH06 · last 1 Jul 20261 · 2

Same industry

ABBV AbbVieLeading+19%
VTRS ViatrisLeading+13%

Distance from each stock’s own 150-day average.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202583.0%
Cash conversionFY 2025 · to 31 Dec 202581.5%
Debt to equityFY 2025 · to 31 Dec 20251.60×
Share count trendFY 2025 · to 9 Feb 20264.9%
Cash and equivalentsFY 2025 · to 31 Dec 2025$7.3B

Analyst forecasts

No analyst forecasts yet.